Specific adverse events predict survival rates in a Chinese population diagnosed with hepatocellular carcinoma and treated with sorafenib

Hepatocellular carcinoma (HCC) is associated with a poor prognosis and a low chemotherapeutic efficiency except for when sorafenib is administered. The aim of this study was to evaluate the efficacy and adverse events (AEs) of sorafenib therapy in a Chinese population diagnosed with HCC. METHOD: Dat...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:JGH Open
Prif Awduron: Lee, Shou‐Wu, Lee, Teng‐Yu, Yang, Sheng‐Shun, Peng, Yen‐Chun, Yeh, Hong‐Zen, Chang, Chi‐Sen
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Wiley Publishing Asia Pty Ltd 2018
Pynciau:
Original Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6386742/
https://ncbi.nlm.nih.gov/pubmed/30834335
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jgh3.12096
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg